The liposome conjugated with anti-NCOA3 antibodies provides a new strategy for targeted therapy in melanoma, as NCOA3 is a key factor in regulating tumor cell proliferation. This liposome can effectively recognize and target tumor cells for the delivery of anticancer drugs. By directing the drug to the tumor site, it can enhance therapeutic efficacy and reduce systemic toxicity. Recent research indicates that its targeting characteristics help control cancer progression.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2199z | Mouse Anti-NCOA3 Recombinant Antibody (clone 37A2) | WB, ELISA, FC, ICC, IF, IHC | Mouse IgG1 |
MOB-0086CT | Recombinant Mouse anti-Human NCOA3 Monoclonal antibody (0.U.209) | IHC-P, IP, WB | |
ZG-0305C | Mouse Anti-NCOA3 Recombinant Antibody (ZG-0305C) | WB, ELISA | Mouse IgG |
VS3-XY1144 | Mouse Anti-NCOA3 Recombinant Antibody (clone 5H3) | ELISA, WB | Mouse IgG2b |
VS3-XY1145 | Mouse Anti-NCOA3 Recombinant Antibody (clone 2C11B12) | ELISA, WB | Mouse IgG1 |
There are currently no Customer reviews or questions for VS-1024-FY194. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.